Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate
ACAD wins FDA's Fast Track status for remlifanserin in Alzheimer's disease psychosis as its phase II data readout approaches and phase III enrollment advances.
Q2 Recap: Markets Get Back on Track
In financial markets, there is a concept known as “the wall of worry.” Put plainly, this concept describes how markets often see past short-term concerns to post positive returns, essentially climbing over the proverbial wall of worry.
Is Lilly Stock On Track To Hit $2,090?
This article was written by Doug Nathman, with research by his team at Trefis.
Q2 Recap: Markets Get Back on Track
Summary Technology drove strong US returns. Emerging Markets lead global returns, despite negative Chinese returns.
Aya Gold & Silver: Growth Remains On Track Despite The Pullback
Aya Gold & Silver is rated a 'buy' due to undervaluation and strong growth prospects from its Moroccan assets. Zgounder remains a high-grade, low-cost silver mine with growing reserves, generating robust cash flow and supporting expansion. Boumadine offers transformative upside, with a large, low-cost polymetallic resource and significant exploration potential not yet reflected in NAV.
Range Resources: Strong Q1 Realized Prices Put It On Track For $800 Million In 2026 Free Cash Flow
Range Resources reported solid Q1 2026 results, with strong differentials for natural gas and NGLs. It also increased its full-year guidance around NGL differentials (compared to Mont Belvieu). Processing costs are expected to be slightly higher, though, due to improved NGL revenues.
JABS: High-Quality ABS ETF, Solid Fundamentals, Good Income And Track-Record
Janus Henderson has several income ETFs, most focusing on higher-quality, niche securities and investments. JABS is one such ETF, focusing on high-quality ABS. These securities have higher yields than more traditional bonds and fixed-income securities of comparable risk. Risk-adjusted returns are high, as are expected returns.
REalloys Reports Progress on Commercial Agreements with the Saskatchewan Research Council; Exclusive Heavy Rare Earth Supply Chain on Track Ahead of 2027 Statutory Deadline
PR Audio: EUCLID, Ohio, SASKATOON, Saskatchewan, May 26, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – REalloys Inc. (NASDAQ: ALOY) (“REalloys” or the “Company”), a U.S.
SMCY's Dreamy Distribution Hides a Track Record Even YieldMax Investors Should Find Concerning
Income investors who bought the YieldMax SMCI Option Income Strategy ETF (NYSEARCA:SMCY) wanted exposure to Super Micro Computer's volatility without owning the stock outright.
Micron's Road To $1,000 Is On Track
Micron stock surged another 80%, yet valuation remains near 7x forward earnings despite exploding AI infrastructure demand. AI bottlenecks increasingly revolve around memory, storage, and bandwidth, positioning Micron at the center of next-generation AI architectures. Micron's 1-gamma EUV transition improved manufacturing efficiency, supporting higher margins through better yields, density, and power optimization.
Intesa Sanpaolo: On Track To Meet Medium-Term Financial Targets
Intesa Sanpaolo remains a 'Buy' despite geopolitical risks, supported by resilient Q1 2026 earnings. Q1 net income was a record €2.8 billion, mapping to a 25% return on tangible equity, and credit charges were well below management's medium-term plan assumptions. Pre-provision income grew 9% year-on-year. Cost control and rising fee income underpin the investment case even amid inflationary pressures.
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data
IDEAYA Biosciences NASDAQ: IDYA said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also highlighting several pipeline programs during a presentation at the Bank of America Global Healthcare Conference.
